Scancell Holdings - SCIB1 Phase 1/2 clinical trial results presented at ASCO and DNA ImmunoBody patent granted in United States | Broadcast | BRR Media

00:00

00:00

00:00

Scancell Holdings - SCIB1 Phase 1/2 clinical trial results presented at ASCO and DNA ImmunoBody patent granted in United States

SCLP Sun, 08 Jun 2014, 22:40 BST

Dr Richard Goodfellow, Joint Chief Executive Officer dicusses the recent SCIB1 Phase 1/2 clinical trial results presented at ASCO and patent DNA ImmunoBody patent granted in United States.

Dr Richard Goodfellow

Joint Chief Executive Officer

Company Events - SCANCELL HOLDINGS

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

General update and collaboration with ImmunID

Dr Richard Goodfellow, Joint Chief Executive Officer

Fri, 31 Jul 2015, 8:45am BST

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Scancell - Update on SCIB1 data

Dr Richard Goodfellow, Joint Chief Executive Officer

Tue, 2 Jun 2015, 7:10am BST

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Scancell Holdings - SCIB2 also shown to synergise with...

Dr Richard Goodfellow, Joint Chief Executive Officer

Tue, 24 Mar 2015, 2:20pm GMT

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Scancell Holdings - Analyst Interview, Panmure Gordon...

Mike Mitchell, Director, Equity Research, Director

Thu, 11 Dec 2014, 3:00pm GMT

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Scancell Holdings - Half yearly report

Dr Richard Goodfellow, Joint Chief Executive Officer

Wed, 10 Dec 2014, 9:00am GMT

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Scancell Holdings - Synergy of SCIB1 with checkpoint...

Dr Richard Goodfellow, Joint Chief Executive Officer

Wed, 13 Aug 2014, 10:00pm BST

<img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img data-src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36" src="data:image/gif;base64,R0lGODlhAQABAAAAACH5BAEKAAEALAAAAAABAAEAAAICTAEAOw==" class="lazyload" style="--smush-placeholder-width: 36px; --smush-placeholder-aspect-ratio: 36/36;"><noscript><img src="https://www.brrmedia.co.uk/wp-content/themes/salient/img/play-button.png" alt="" width="36" height="36">

Scancell Holdings - SCIB1 Phase 1/2 clinical trial results...

Dr Richard Goodfellow, Joint Chief Executive Officer

Sun, 8 Jun 2014, 10:40pm BST